Singapore markets closed
  • Straits Times Index

    3,166.27
    -55.25 (-1.72%)
     
  • Nikkei

    28,751.62
    -747.66 (-2.53%)
     
  • Hang Seng

    24,080.52
    -659.64 (-2.67%)
     
  • FTSE 100

    7,044.03
    -266.34 (-3.64%)
     
  • BTC-USD

    54,547.64
    -3,243.52 (-5.61%)
     
  • CMC Crypto 200

    1,365.60
    -89.82 (-6.17%)
     
  • S&P 500

    4,594.62
    -106.84 (-2.27%)
     
  • Dow

    34,899.34
    -905.04 (-2.53%)
     
  • Nasdaq

    15,491.66
    -353.57 (-2.23%)
     
  • Gold

    1,785.50
    +1.20 (+0.07%)
     
  • Crude Oil

    68.15
    -10.24 (-13.06%)
     
  • 10-Yr Bond

    1.4820
    -0.1630 (-9.91%)
     
  • FTSE Bursa Malaysia

    1,512.22
    -5.38 (-0.35%)
     
  • Jakarta Composite Index

    6,561.55
    -137.79 (-2.06%)
     
  • PSE Index

    7,278.44
    -90.83 (-1.23%)
     

Global OTC Drugs & Dietary Supplements Market is projected to grow at a CAGR of 5.7% By 2031: Visiongain Research Inc

·7-min read

Global OTC Drugs & Dietary Supplements Market Report Forecast up to 2031 (COVID Impact Analysis):- Market Segment by Distribution Channel (Pharmacies/Drugstores, Supermarkets/Hypermarkets, Convenience Stores, Online Drugstores, Health Food Stores, Other Distribution Channel) Market Segment by Category (Cough, Cold and Flu Drugs, Analgesics, Dermatological, Vitamins and Minerals, Weight Loss/Diet Products, Gastrointestinal Drugs, Allergy, Other Category) Market Segment by Product Type (Branded Drugs, Generic Drugs, Other Product Types) Market Segment by Dosage Form (Tablets, Hard Capsules, Powders, Ointments, Soft Capsules, Liquids, Other Dosage Forms) Market Segment by Allergy Type (Eye Allergy, Rhinitis, Asthma, Skin Allergy, Food Allergies, Other Allergies) Market Segment by Allergy Drugs (Antihistamines, Corticosteroids, Decongestants, Other Allergy Drugs) PLUS COVID-19 Impact Analysis and Recovery Pattern Analysis (V-shaped, W-shaped, U-shaped, L-shaped) Profiles of Leading Companies, Region and Country.

The global OTC drugs & dietary supplements market was valued at US$197.2 billion in 2020 and is projected to grow at a CAGR of 5.7% during the forecast period 2021-2031. Self-care in the global health system becomes a primary public resource. Globally, self-drugs have been accepted as a major element of primary health care by most nations. The usage of medications and dietary supplements is a matter of self-care. In many countries, the use of traditional treatments and supplements is an ancient practice.

Download Exclusive Sample of Report @ https://www.visiongain.com/report/otc-drugs-market-2021/#download_sampe_div

How has COVID-19 had a significant negative impact on the OTC Drugs & Dietary Supplements Market?

During the outbreak of Severe ARS2 (SARS-CoV-2), the World Health Organization (WHO) on 30 December 2020 was recognized as a worldwide public-medical emergency. Although pharmacies were still open, some customers buying on the e-commerce channel rather than the regular channels because, for example, they changed to remote work or restricted other departures. The limits established have resulted in a decreased number of visitors and, therefore, OTC sales through the retail chain were reduced. As other health practitioners were not accessible at this time, the pressure on the health system was lessened by local pharmacists, diverting patient intake from hospitals through triage and screening. During COVID-19, Community pharmacists played different roles in the support of the health system.

How this Report Will Benefit you?

Visiongain’s 593+ page report provides 311 tables and 302 charts/graphs. Our new study is suitable for anyone requiring commercial, in-depth analyses for the global OTC drugs & dietary supplements market, along with detailed segment analysis in the market. Our new study will help you evaluate the overall global and regional market for OTC Drugs & Dietary Supplements. Get the financial analysis of the overall market and different segments including distribution channel, product type, category, allergy type, allergy drugs and capture higher market share. We believe that high opportunity remains in this fast-growing OTC drugs & dietary supplements market. See how to use the existing and upcoming opportunities in this market to gain revenue benefits in the near future. Moreover, the report would help you to improve your strategic decision-making, allowing you to frame growth strategies, reinforce the analysis of other market players, and maximize the productivity of the company.

What are the current market drivers?

Self-Care in The Global Health System Becomes a Primary Public Resource

People in emerging and industrialized countries are now aware of their health, and fitness and wellness programs are growing worldwide. Immunization and vaccination, precautionary steps to decrease mortality among children and raise children's immunity, improved living standards in many healthy dietary countries and nutritional supplements are major efforts that have been adopted globally to extend people's life expectancy.

Importance of Dietary Supplement Quality Education Campaigns

Public health agencies, enforcement agencies, associations, industry and other groups should invest in educational programs which provide advice on picking food supplements of quality and describe potential risks of goods that are not self-assured in their identity or quality. Consumers should be made aware that independent verification procedures from third parties can help establish the representations of products and ingredients. Sensitizing campaigns should focus on the most sensitive or expected physiological impacts of low-quality foodstuffs in consumers' segments (e.g. senior citizens, pregnant women, military peoples etc.)

Where are the market opportunities?

Growth Opportunities Will Emerge as a Result of Demographic and Economic Changes

The increasing worldwide population will expand OTC's client base and significantly increase the older population by buying more OTC items. As individuals live longer, they require more medicine to treat age-related conditions, many of which are chronic and require medication throughout their lives. Concerning economic developments in China and the effect of falling oil prices on the economy, there is a strong consensus that the world economy is going to achieve some balance that is likely to reflect sales growth on many OTC markets in 2017, despite currency fluctuations and volatility in the last couple year. From a long-term perspective, the rapid growth of the mid-class economy will enhance the demand for OTC products in emerging economies such as China, India and Brazil.

Get Detailed TOC @ https://www.visiongain.com/report/otc-drugs-market-2021/#download_sampe_div

Emerging Markets Are Booming.

Many economies such as China and India are also striving to enhance the provision and access to healthcare, although these objectives were mostly achieved in existing markets. As a result, during the forecast period, emerging markets will likely remain moderately to highly growing markets. For this research, many companies have noted that their revenues continue to expand in overseas markets compared to their home revenues.

Competitive Landscape

The major players operating in the OTC drugs & dietary supplements market are Taisho Pharmaceutical Holdings Co., Ltd, Nippon Chemiphar Co., Ltd., H Lundbeck A/S, Teva Pharmaceutical Industries Ltd, Novartis AG, Pfizer Inc., Mylan N.V., Abbott Laboratories, Fresenius SE & Co KgaA, Sun Pharmaceutical Industries, Sanofi SA, Roche Holding AG, Lupin, Alcon AG, Sato Pharmaceutical, Herbalife Nutrition Ltd, Bayer AG., Glanbia plc, Nature’s Sunshine Products, Inc. (NSP), Danisco. These major players operating in this market have adopted various strategies comprising M&A, investment in R&D, collaborations, partnerships, regional business expansion, and new product launches.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence

To access the data contained in this document please email contactus@visiongain.com

Information found nowhere else.

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the anti-obesity drugs market and leading companies. You will find data, trends and predictions.

Find more Visiongain research reports on Pharma Therapeutic Sector; click on the following links:

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: catherine.walker@visiongain.com

About Visiongain

Visiongain is one of the fastest growing and most innovative, independent, market intelligence around, the company publishes hundreds of market research reports which it adds to its extensive portfolio each year. These reports offer in-depth analysis across 18 industries worldwide. The reports cover a 10-year forecast, are hundreds of pages long, with in depth market analysis and valuable competitive intelligence data. Visiongain works across a range of vertical markets, which currently can influence one another, these markets include automotive, aviation, chemicals, cyber, defense, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors. Our customized and syndicated market research reports mean that you can have a bespoke piece of market intelligence customized to your very own business needs.

Contact:

Catherine Walker
PR at Visiongain Inc.
Tel: + 44 0207 336 6100
USA Tel: + 1 718 682 4567
EU Tel: + 353 1 695 0006
Toll Free: 00-1-646-396-5129
Email: catherine.walker@visiongain.com
Web: https://www.visiongain.com
Follow Us: LinkedIn | Twitter

-

SOURCE Visiongain Limited.


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting